Press-release for stocks related to test

| -2.53% | O: 0.33% H: 0.82% C: -2.9%
defense test security family

Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
LH M | $199.97 -0.97% 0.0% 680K

| -2.8% | O: 0.82% H: 0.0% C: 0.0%
test blood for neurodegenerative labcorp

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
DARE | $0.2843 -41.37% -70.56% 4.2M

| 1.32% | O: 1.36% H: 0.68% C: -0.64%
ovaprene test positive bioscience publication contraceptive contraception study

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published: 2024-04-11 (Crawled : 05:00) - globenewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M

| -0.14% | O: 1.06% H: 0.47% C: -0.03%
fda device disease test granted blood designation for alzheimer's roche

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL | News M | $38.68 -4.02% -4.19% 750K

| -13.26% | O: -2.64% H: 2.3% C: 1.24%
vitros partnership test assay

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
PRPH | $6.21 -15.51% -18.36% 82K

| -3.69% | O: -7.22% H: 2.98% C: 1.49%
management test cancer

Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
LH M | $199.97 -0.97% 0.0% 680K

| -5.27% | O: -0.9% H: 0.0% C: 0.0%
fda test authorization for home labcorp

Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
EXAS | $63.21 -1.02% -1.03% 2.5M

| -9.07% | O: 0.21% H: 0.0% C: 0.0%
test sciences meeting study

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | $90.33 0.01% 0.01% 680K

| -6.64% | O: 0.92% H: 0.26% C: -2.26%
test for heart

Kanders & Company Announces Definitive Agreement to Acquire Antenna and Test Equipment Businesses from L3Harris
Published: 2024-04-05 (Crawled : 12:30) - prnewswire.com
LHX | $201.4 0.53% -0.43% 900K

| -2.17% | O: 1.46% H: 0.37% C: 0.04%
company test acquire agreement

Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test
Published: 2024-04-03 (Crawled : 11:00) - prnewswire.com
DHR | $239.39 -0.4% 0.03% 2.9M

| -2.28% | O: 0.02% H: 0.85% C: -0.67%
xpert test health world

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
DGX | $126.98 -0.35% -0.18% 890K

| -5.45% | O: -0.13% H: 0.0% C: -1.72%
test genetic diagnostics

Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABT | News | $105.9 -3.03% 0.07% 12M

| -4.68% | O: 0.38% H: 0.0% C: -1.38%
fda test rapid blood clearance

Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
EXAS | $63.21 -1.02% -1.03% 2.5M

| -4.52% | O: 0.96% H: 0.0% C: 0.0%
oncoguard test cancer sciences

VIAVI Demonstrates Leadership in RAN Intelligence Test and Training at 2024 RIC Forum
Published: 2024-03-28 (Crawled : 11:00) - prnewswire.com
VIAV | $8.16 -1.92% -1.96% 1.4M

| -14.72% | O: -0.1% H: 0.31% C: -5.02%
test intelligence

Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
Published: 2024-03-26 (Crawled : 17:00) - biospace.com/
PSNL | $1.2 -3.23% -3.33% 360K

| -16.67% | O: 4.17% H: 2.0% C: -4.67%
personal test cancer publication treatment response

Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
DGX | $126.98 -0.35% -0.18% 890K

| -1.44% | O: 0.26% H: 0.1% C: -0.58%
disease test blood alzheimer's imaging study

QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
QGEN | $39.23 -0.23% 0.0% 800K

| -8.38% | O: -1.59% H: 1.33% C: 1.33%
QGEN | $39.23 -0.23% 0.0% 800K

| -8.38% | O: -1.59% H: 1.33% C: 1.33%
test system collaboration results

GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
GENE | News | $3.12 -1.58% -1.6% 13K

| 18.35% | O: 1.12% H: 1.85% C: -5.19%
test risk advanced

BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Published: 2024-03-22 (Crawled : 11:00) - prnewswire.com
TECH | $62.7 -2.05% -2.09% 900K

| -13.27% | O: 0.07% H: 0.1% C: -1.22%
certification test diagnostic leukemia

← Previous
1
2
3
4
5
6
7
8
9
…
112
113
Next →

Gainers vs Losers

56%

44%

Top 10 Gainers

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

Manufacturing

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M